Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.10
-0.01 (-0.14%)
At close: Apr 17, 2026

HKG:2566 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,7321,8551,620---
Market Cap Growth
2.42%14.54%----
Enterprise Value
1,1161,4191,716---
Last Close Price
7.177.566.56---
PE Ratio
11.4212.0510.98---
PS Ratio
1.191.281.11---
PB Ratio
0.941.011.00---
P/TBV Ratio
0.941.011.00---
P/FCF Ratio
--19.10---
P/OCF Ratio
--16.06---
EV/Sales Ratio
0.770.981.18---
EV/EBITDA Ratio
5.687.228.38---
EV/EBIT Ratio
7.109.0310.27---
EV/FCF Ratio
--20.24---
Debt / Equity Ratio
0.100.100.080.190.290.28
Debt / EBITDA Ratio
0.910.910.620.962.701.32
Debt / FCF Ratio
--1.521.46-15.02
Net Debt / Equity Ratio
-0.33-0.33-0.320.050.140.11
Net Debt / EBITDA Ratio
-3.13-3.13-2.550.241.290.50
Net Debt / FCF Ratio
---6.160.36-141.555.61
Asset Turnover
0.650.650.851.020.94-
Inventory Turnover
1.661.661.801.741.45-
Quick Ratio
3.963.963.661.881.621.34
Current Ratio
4.464.464.132.422.131.87
Return on Equity (ROE)
8.74%8.74%11.47%14.39%8.07%-
Return on Assets (ROA)
4.37%4.37%6.08%6.81%2.39%-
Return on Invested Capital (ROIC)
11.05%11.41%13.13%13.48%5.51%15.36%
Return on Capital Employed (ROCE)
7.90%7.90%9.90%14.30%5.40%16.60%
Earnings Yield
8.89%8.30%9.11%---
FCF Yield
--5.24%---
Dividend Yield
0.92%0.84%0.91%---
Payout Ratio
----20.04%-
Buyback Yield / Dilution
-20.16%-20.16%-2.11%---
Total Shareholder Return
-19.23%-19.32%-1.21%---
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.